Luminary Therapeutics: Funding, Investors & Team (Oct 2026)
Luminary is a clinical stage CAR-T therapy company with a novel allogeneic manufacturing platform where our CAR and or TCR development utilizes gamma delta cells. What makes our allogeneic therapeutics unique are that our final drug product includes the combinatory power of both the Vẟ1 and Vẟ2 gamma delta cells giving our therapies the power of both innate and adaptive cancer clearing power. We have multiple solid tumor targets under development with a proprietary signaling method to ensure T-Cell persistence. Additionally, our Ligand BAFF CAR for hematologic cancers is designed with 3 antigen receptors specifically designed to overcome antigen escape. For more information visit www.luminarytx.com
Luminary Therapeutics has raised $6.1M across 2 funding rounds on record, the most recent an undisclosed round of $5.8M announced in Mar 2025.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Luminary Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2025.
Luminary Therapeutics Funding Rounds
Luminary Therapeutics raised $300k in an undisclosed round announced in Oct 2024.
5 months later, an undisclosed round of $5.8M was announced in Mar 2025.
Luminary Therapeutics Founders and Leadership Team
Contact details for the Luminary Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Luminary Therapeutics Funding Compared to Other Biotechnology Startups
Luminary Therapeutics' latest round of $5.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Luminary Therapeutics in Biotechnology and Minneapolis
Companies Similar to Luminary Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Luminary Therapeutics Funding FAQs
What does Luminary Therapeutics do?
Luminary is a clinical stage CAR-T therapy company with a novel allogeneic manufacturing platform where our CAR and or TCR development utilizes gamma delta cells. What makes our allogeneic therapeutics unique are that our final drug product includes the combinatory power of both the Vẟ1 and Vẟ2 gamma delta cells giving our therapies the power of both innate and adaptive cancer clearing power. We have multiple solid tumor targets under development with a proprietary signaling method to ensure T-Cell persistence. Additionally, our Ligand BAFF CAR for hematologic cancers is designed with 3 antigen receptors specifically designed to overcome antigen escape. For more information visit www.luminarytx.com
How much funding has Luminary Therapeutics raised?
Luminary Therapeutics has raised $6.1M across 2 rounds on record. The most recent is an undisclosed round of $5.8M announced in Mar 2025.
When did Luminary Therapeutics last raise funding?
Luminary Therapeutics' most recent funding round on record is an undisclosed round of $5.8M, announced in Mar 2025.
Who founded Luminary Therapeutics?
FundedIQ lists Beau Webber (Founder) at Luminary Therapeutics.
Where is Luminary Therapeutics headquartered?
Luminary Therapeutics is based in Minneapolis, Minnesota, United States.
How many employees does Luminary Therapeutics have?
Luminary Therapeutics is in the 1-10 employee band.
How does Luminary Therapeutics' funding compare to other Biotechnology startups?
Luminary Therapeutics' latest round of $5.8M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Luminary Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Luminary Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.